An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EX...

Por Galle, Jan-Christoph, Claes, Kathleen, Kiss, Istvan, Winearls, Christopher G., Herlitz, Hans, Guerin, Alain, Di Giulio, Salvatore, Suranyi, Michael G., Bridges, Ian, Addison, Janet, Farouk, Mourad
Publicado em 2012

Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

Por Galle, Jan-Christoph, Addison, Janet, Suranyi, Michael G., Claes, Kathleen, Di Giulio, Salvatore, Guerin, Alain, Herlitz, Hans, Kiss, István, Farouk, Mourad, Manamley, Nick, Wirnsberger, Gerhard, Winearls, Christopher
Publicado no Nephrol Dial Transplant (2016)

The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

Por Johnson, David W., Brown, Fiona G., Clarke, Margaret, Boudville, Neil, Elias, Tony J., Foo, Marjorie W.Y., Jones, Bernard, Kulkarni, Hemant, Langham, Robyn, Ranganathan, Dwarakanathan, Schollum, John, Suranyi, Michael G., Tan, Seng H., Voss, David
Publicado em 2012

The Effects of Biocompatible Compared with Standard Peritoneal Dialysis Solutions on Peritonitis Microbiology, Treatment, and Outcomes: the balANZ Trial

Por Johnson, David W., Brown, Fiona G., Clarke, Margaret, Boudville, Neil, Elias, Tony J., Foo, Marjorie W.Y., Jones, Bernard, Kulkarni, Hemant, Langham, Robyn, Ranganathan, Dwarakanathan, Schollum, John, Suranyi, Michael G., Tan, Seng H., Voss, David
Publicado em 2012